RYTARYTM (IPX066) (Carbidopa And Levodopa) Extended-Release Capsules Phase III And Open-Label Extension Data To Be Presented At The American Academy Of Neurology Conference
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ:
IPXL), today announced that data from the RYTARY
TM Phase III
and open-label extension trials will be presented at the 65th Annual
Meeting of the...